A retrospective study of the Framingham cardiovascular risk scores in a liver transplant population

Transplantation Proceedings

Volumn 45, Issue 1, 2013, Pages 308-314

  Mansell, H ^a   Worobetz, L J ^b   Sylwestrowicz, T ^b   Shoker, A S ^a  

^a Saskatoon Health Region St Pauls Hospital   (Canada)

^b ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; CARDIOVASCULAR RISK; DIABETES MELLITUS; FEMALE; FRAMINGHAM CARDIOVASCULAR RISK SCORE; FRAMINGHAM RISK SCORE; GLOMERULUS FILTRATION RATE; HIGH RISK POPULATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PREDICTIVE VALUE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCLEROSING CHOLANGITIS; SMOKING;

ADULT; AGED; ALGORITHMS; CARDIOLOGY; CARDIOVASCULAR DISEASES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MASS SPECTROMETRY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; YOUNG ADULT;

EID: 84873290807     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.04.039     Document Type: Article

References (55)

1. R. Kashyap, A. Jain, J. Reyes Causes of death after liver transplantation in 4000 consecutive patients: 2-19 year follow-up Transplant Proc 33 2001 1482
2. J. Pruthi, K.A. Medkiff, K.T. Esrason Analysis of causes of death in liver transplant recipients who survived more than 3 years Liver Transpl 7 2001 811
3. S.D. Johnston, J.K. Morris, R. Cramb Cardiovascular morbidity and mortality after orthotopic liver transplantation Transplantation 73 2002 901
4. F. Mazuelos, J. Abril, C. Zaragoza Cardiovascular morbidity and obesity in adult liver transplant recipients Transplant Proc 35 2003 1909
5. O. Ciccarelli, B. Kaczmarek, F. Roggen Long-term medical complications and quality of life in adult recipients surviving 10 years or more after liver transplantation Acta Gastroenterol Belg 68 2005 232
6. S. Desai, J.C. Hong, S. Saab Cardiovascular risk factors following orthotopic liver transplantation: predisposing factors, incidence and management Liver Int 30 2010 948
7. C.O. Zein, C. Levy, A. Basu Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study Am J Gastroenterol 100 2005 48
8. M.E. Allison, T. Wreghitt, C.R. Palmer Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population J Hepatol 21 1994 1135
9. A. Laish, M. Braun, E. Mor Metabolic syndrome in liver transplant recipients: prevalence, risk factors and association with cardiovascular events Liver Transpl 17 2011 15
10. V.J. Canzanello, L. Schwartz, S.J. Taler Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506) Liver Transpl Surg 3 1997 1
11. F. Di Benedetto, S. Di Sandro, N. De Ruvo Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors J Clin Gastroenterol 43 2009 280
12. B.D. Myers, J. Ross, L. Newton Cyclosporine-associated chronic nephropathy N Engl J Med 311 1984 699
13. A.O. Ojo, P.J. Held, F.K. Port Chronic renal failure after transplantation of a nonrenal organ N Engl J Med 349 2003 931
14. B.J. Nankivell, J.R. Chapman Chronic allograft nephropathy: current concepts and future directions Transplantation 8 1992 875
15. S.L. White, K.R. Polkinghorne, R.C. Atkins Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study Am J Kidney Dis 55 2010 660
16. J. Genest, R. McPherson, J. Frohlich 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendation Can J Cardiol 25 2009 567
17. R.B. D'Agostino Sr, R.S. Vasan, M.J. Pencina General cardiovascular risk profile for use in primary care The Framingham Heart Study Circulation 117 2008 743
18. B.L. Kasiske, H.A. Chakkera, J. Roel Explained and unexplained ischemic heart disease after renal transplantation J Am Soc Nephrol 11 2000 1735
19. D. Ducloux, A. Kazory, J.M. Chalopin Predicting coronary heart disease in renal transplant recipients: a prospective study Kidney Int 66 2004 441
20. B. Kiberd, R. Panek Cardiovascular outcomes in the outpatient kidney transplant clinic: the Framingham score revisited Clin J Am Soc Nephrol 3 2008 822
21. M.C. Banas, B. Banas, S.R. Orth Traditional and nontraditional cardiovascular risk factors and estimated risk for coronary artery disease in renal transplant recipients: a single-center experience Nephron Clin Pract 119 2011 c227
22. H. Elmoselhi, M.A. Hossain, S. Khamis The practical implications of using estimated GFR as the presumed reference variable to estimate transplant chronic kidney disease Nephrol Rev 3 2011 e2
23. M. Emara, A. Zahran, H. Abd El Hady How to best define patients with moderate chronic kidney disease Nephron Clin Pract 110 2008 c195
24. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 33 suppl 1 2010 S62
25. D.A.J. Neal, B.D.M. Tom, T. Luan Is there disparity between risk and incidence of cardiovascular disease after liver transplant Transplantation 77 2004 93
26. M. Albeldawi, A. Ashish, S. Madhwal Cumulative risk of cardiovascular events following orthotopic liver transplantation Liver Transpl 18 2012 370
27. F. Wang, P. Ye, L. Luo Association of risk factors for cardiovascular disease and glomerular filtration rate: a community-based study of 4925 adults in Beijing Nephrol Dial Transplant 25 2010 3924
28. P. Muntner, J. He, L. Hamm Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States J Am Soc Nephrol 13 2002 745
29. R.M. Henry, P.J. Kostense, G. Bos Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study Kidney Int 62 2002 1402
30. G. Manjunath, H. Tighiouart, J. Coresh Level of kidney function as a risk marker for cardiovascular outcomes in the elderly Kidney Int 63 2003 1121
31. J.F. Mann, H.C. Gerstein, J. Pogue Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial Ann Intern Med 134 2001 629
32. As Go, G.M. Chertow, D. Fan Chronic kidney disease and the risks of death, cardiovascular events and hospitalization N Engl J Med 351 2004 1296
33. Chronic Kidney Disease Prognosis Consortium K. Matsushita, M. van der Velde et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2010 2073
34. D.E. Weiner, H. Tighiouart, M.G. Amin Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies J Am Soc Nephrol 15 2004 1307
35. H.U. Meier-Kriesche, R. Bailga, B. Kaplan Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation Transplantation 75 2003 1291
36. S. Arora, A. Andreassen, S. Simonsen Prognostic importance of renal function 1 year after heart transplantation for all-cause and cardiac mortality and development of allograft vasculopathy 84 Transplantation 27 2007 149
37. O. Guckelberger, F. Mutzke, M. Glanemann Validation of cardiovascular risk scores in a liver transplant population Liver Transpl 12 2006 394
38. K.C. Abbott, C.M. Yuan, A.J. Taylor Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression J Am Soc Nephrol 14 2003 235
39. H.L. Hillege, A.R. Girbes, P.J. de Kam Renal function, neurohormonal activation, and survival in patients with chronic heart failure Circulation 102 2000 203
40. M. Laryea, K.D. Watt, M. Molinari Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events Liver Transpl 13 2007 1109
41. J.I. Moon, R. Barbeito, R.N. Faradji Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: long-term follow up Transplantation 82 2006 1652
42. P.R. John, P.J. Thuluvath Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus Liver Transpl 8 2002 708
43. F.G. Cosio, T.E. Pesavento, S. Kim Patient survival after renal transplantation: IV Impact of post-transplant diabetes Kidney Int 62 2002 1440
44. S. Beckebaum, C. Klein, J. Varghese Renal function and cardiovascular risk profile after conversion from cyclosporine to tacrolimus: a prospective study in 80 liver transplant recipients Aliment Pharmacol Ther 30 2009 834
45. O. Guckelberger, A. Byram, J. Klupp Coronary event rates in liver transplant recipients reflect the increased prevalence of cardiovascular risk-factors Transpl Int 18 2005 967
46. S.A. Grover, I. Lowensteyn, L. Joseph Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial Arch Intern Med 167 2007 2296
47. K. Eichler, M.A. Puhan, J. Steurer Prediction of first coronary events with the Framingham score: a systematic review Am Heart J 153 2007 722
48. B.A. Hemann, W.F. Bimson, A.J. Taylor The Framingham Risk Score: an appraisal of its benefits and limitations Am Heart Hosp J 5 2007 91
49. R.B. D'Agostino Sr, S. Grundy, L.M. Sullivan CHD Risk Prediction Group Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation JAMA 286 2001 180
50. J.N. Bosomworth Practical use of the Framingham risk score in primary prevention Can Fam Physician 57 2011 417
51. S.A. Silver, M. Huang, M.M. Nash Framingham risk score and novel cardiovascular risk factors underpredict major cardiac events in kidney transplant recipients Transplantation 92 2011 183
52. D. Ducloux, G. Motte, B. Challier Serum total homocysteine and cardiovascular disease in chronic, stable renal transplant recipients: a prospective study J Am Soc Nephrol 11 2002 134
53. M. Acampa, P.E. Lazzerini, F. Guideri Homocysteine and P wave dispersion in patients with heart transplantation Clin Transplant 25 2011 119
54. P. Przybylowski, J. Malyszko, J. Malyszko Anemia is a predictor of outcome in heart transplant recipients Transplant Proc 41 2009 3228
55. A.K. Israni, J.J. Snyder, M.A. Skeans PORT Investigators Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study Am J Transplant 10 2010 338